Literature DB >> 11238356

Is the MMR vaccine safe?

C Edwards1.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11238356      PMCID： PMC1071313          DOI： 10.1136/ewjm.174.3.197

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  5 in total

1.  No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study.

Authors:  H Peltola; A Patja; P Leinikki; M Valle; I Davidkin; M Paunio
Journal:  Lancet       Date:  1998-05-02       Impact factor: 79.321

2.  Vaccine adverse events: causal or coincidental?

Authors:  R T Chen; F DeStefano
Journal:  Lancet       Date:  1998-02-28       Impact factor: 79.321

3.  Reactions to MMR immunization scare.

Authors:  K Birmingham; M Cimons
Journal:  Nat Med       Date:  1998-05       Impact factor: 53.440

4.  Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association.

Authors:  B Taylor; E Miller; C P Farrington; M C Petropoulos; I Favot-Mayaud; J Li; P A Waight
Journal:  Lancet       Date:  1999-06-12       Impact factor: 79.321

5.  Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children.

Authors:  A J Wakefield; S H Murch; A Anthony; J Linnell; D M Casson; M Malik; M Berelowitz; A P Dhillon; M A Thomson; P Harvey; A Valentine; S E Davies; J A Walker-Smith
Journal:  Lancet       Date:  1998-02-28       Impact factor: 79.321
  5 in total
  2 in total

Review 1.  A comprehensive overview of vaccines developed for pandemic viral pathogens over the past two decades including those in clinical trials for the current novel SARS-CoV-2.

Authors:  Kannan Damodharan; Gandarvakottai Senthilkumar Arumugam; Suresh Ganesan; Mukesh Doble; Sathiah Thennarasu
Journal:  RSC Adv       Date:  2021-06-08       Impact factor: 4.036

Review 2.  A review of vaccine effects on women in light of the COVID-19 pandemic.

Authors:  Wen-Han Chang
Journal:  Taiwan J Obstet Gynecol       Date:  2020-09-11       Impact factor: 1.705
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.